Navidea Biopharmaceuticals Inc.
425 Metro Place North, Suite 450
Dublin
OH
43017
USA
(614) 793-7500
http://navidea.com/

Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers
Navidea, Mass General Evaluate Nuclear Imaging Agent for Vulnerable Plaque Detection

July 30, 2015 — Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of ...

Home July 30, 2015
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now